Increased Soluble PD-1 Predicts Response to Nivolumab plus Ipilimumab in Melanoma

por Pedersen, Jesper Geert, Sokac, Mateo, Sørensen, Boe Sandahl, Luczak, Adam Andrzej, Aggerholm-Pedersen, Ninna, Birkbak, Nicolai Juul, Øllegaard, Trine Heide, Jakobsen, Martin Roelsgaard
Publicado 2022

Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panel

por Kisistók, Judit, Christensen, Ditte Sigaard, Rasmussen, Mads Heilskov, Duval, Lone, Aggerholm-Pedersen, Ninna, Luczak, Adam Andrzej, Sorensen, Boe Sandahl, Jakobsen, Martin Roelsgaard, Oellegaard, Trine Heide, Birkbak, Nicolai Juul
Publicado 2023